TrialBMC medicine2026

Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial.

Zhiming Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.